Florida Attorney General Issues Subpoena to CVS Health in Pharmacy Probe -- Barrons.com

Dow Jones
06/24

By Catherine Dunn

The Florida attorney general's office said on Tuesday that it's probing the relationship between CVS Health's retail pharmacies and its pharmacy benefit manager, or PBM, business. The announcement adds another pressure point to an industry under bipartisan scrutiny across states and in Washington, including calls to break up ownership of PBMs and pharmacies by the same company.

PBMs help decide which drugs are covered by an insurance plan, in addition to managing the pharmacy networks where consumers fill prescriptions. The industry says it plays an important role in managing healthcare costs for clients, such as large employers that sponsor health plans, and a plan's members.

Florida AG James Uthmeier said he is examining whether CVS's PBM steers patients to its own pharmacies and pays its pharmacies higher reimbursements than it pays to independent pharmacies. Those practices allegedly contribute to pharmacy closures, "leaving families and seniors with fewer options and higher costs," the AG's office said.

"Here you have a situation where it appears one company has gotten so big that they are controlling market power in a way that might manipulate pricing at the cost of consumers," Uthmeier said during a press conference.

As part of the probe, the state attorney general issued a civil investigative demand to CVS Health with a July 28 deadline. The subpoena requests documents and sworn testimony covering pharmacy contracts, reimbursement rates, "differential treatment of own versus independent stores," and the company's expansion plans, according to a press release. CVS operates about 800 pharmacies in Florida.

A spokesman for CVS said the company "will work with the Florida Attorney General to address any concerns."

"Independent pharmacies remain vital to CVS Caremark's networks, and we collaborate with them to ensure all members have convenient access to the care they need," spokesman David Whitrap told Barron's. "We welcome the opportunity to work with regulators and policymakers to set the record straight around these market dynamics, and more importantly, to improve consumer experience and affordability."

Write to Catherine Dunn at catherine.dunn@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

June 23, 2026 17:33 ET (21:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10